Quantum BioPharma Ltd.
QNTM
$3.02
-$0.34-9.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -46.17% | -3.01% | |||
| Depreciation & Amortization | -10.94% | 2.76% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -49.27% | -3.61% | |||
| Operating Income | 49.27% | 3.61% | |||
| Income Before Tax | 22.00% | 51.39% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 22.00% | 51.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 218.41% | -211.32% | |||
| Net Income | 43.10% | 42.52% | |||
| EBIT | 49.27% | 3.61% | |||
| EBITDA | 50.49% | 3.81% | |||
| EPS Basic | 43.56% | 54.31% | |||
| Normalized Basic EPS | 11.22% | 47.69% | |||
| EPS Diluted | 43.56% | 54.31% | |||
| Normalized Diluted EPS | 11.22% | 47.69% | |||
| Average Basic Shares Outstanding | 0.81% | 25.83% | |||
| Average Diluted Shares Outstanding | 0.81% | 25.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||